UroGen Pharma Ltd. (NASDAQ:URGN) Q2 2023 Earnings Call Transcript

Jeff Bova: So the convenience that 102 offers, you just don’t have as big of a operational lift. As I said earlier, if we deliver product mix, I believe most of this will be given in the clinic, it can be given by an extender, so you don’t have to worry about setting up or time getting this product off through formulary at the hospital institution. So I think, we’ve learned that having a mixed product delivered is something that we definitely need for the community accounts. And that level of aggressiveness with regards to being partners with the urologists, they’re surgeons, they do surgery. So making sure that our messaging and positioning are strong to partner with them and not be reserved for someone who had six or seven TURBT.

The other thing that we’ll caveat is that certainly from a business standpoint, the convenience for the urologists from that as well this will be another buy and build drug that that can be given in the clinic. So a lot of learnings will be overcome just by the sheer convenience of 102, but then certainly how we message, how we partner with urologists, that’s going to significantly help with the launch curve of 102.

Operator: Thank you. I am showing no further questions at this time. So I’d now like to turn the conference back to Liz Barrett for closing remarks.

Liz Barrett: Great, thank you, operator. As always, we appreciate you taking the time to join us today. As I mentioned earlier, it’s an unprecedented time, not only for our company but for patients with urothelial cancers. I’m inspired every day by the commitment of our colleagues that have remained steadfast in their belief and our ability to advance care for patients in need. So we look forward to the next few months and to continue dialog with you. Thanks again for your interest in UroGen and for joining us today. So operator, you can disconnect now. Thank you.

Operator: This concludes today’s conference call. Thank you for participating. Everyone may disconnect.